Shots: The ...
Shots: The 3-armed P-III (DUO-E) study assesses 1L Imfinzi (durvalumab) + CT (carb...
Shots: Asieris has presented results from the P-III clinical evaluation of APL-170...
Shots: The P-III (RUBY) study assesses Jemperli + CT (carboplatin-paclitaxel) foll...
Shots: Following the IND clearance in Jan 2024, Cybin has commenced the P-II PoC t...
Shots: The P-III (